<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114125">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01656967</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-10-0604</org_study_id>
    <nct_id>NCT01656967</nct_id>
  </id_info>
  <brief_title>AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA</brief_title>
  <official_title>Flexible Optical Intubation Via the AMBU Aura-I Versus Blind Intubation Via the Fastrach Single Use Intubating LMA - A Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AMBU A/S (Ballerup, Denmark)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the Ambu® Aura-I  to the Intubating Laryngeal Mask
      Airway (LMA) regarding time to intubate, ease of insertion, sealing properties, optical view
      upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation,
      airway morbidity, and patient comfort in patients undergoing general anesthesia for elective
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Total Intubation Time</measure>
    <time_frame>The Duration of Intubation. Calculated by addition of LMA insertion time and ETT insertion time (Approximately 40 - 250 seconds)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total Intubation Time includes time for LMA insertion and Tube Insertion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time for LMA Insertion</measure>
    <time_frame>LMA Insertion from the time the LMA cuff is placed at the patient's lips until the a CO2 tracing is observed (Approximately 20-100 seconds)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time required to insert LMA. The AMBU Aura-I LMA will be used in Group 1, whereas the Fastrach Single Use Intubating LMA will be used for Group 2 patients. Time will be recorded from when the LMA is at the patient's lips to when a CO2 trace is recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation Time</measure>
    <time_frame>Duration of Tube Insertion, From the time the Tube is at the patient's lips until a CO2 tracing is recorded (Approximately 40-250 seconds)</time_frame>
    <safety_issue>No</safety_issue>
    <description>After the LMA is inserted, time for intubation will be recorded. The AScope 2 disposable fiberoptic camera will be used to assist with intubation for Group 1 patients. Group 2 patients will be intubated using the LMA-Fastrach EndoTracheal Tube.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation Success Rate</measure>
    <time_frame>Duration of Intubation (Approximately 3 minutes)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of attempts required for successful intubation will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Ease of Intubation</measure>
    <time_frame>Duration of Intubation (Approximately 3 minutes)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjective Difficulty of intubation will be recorded by the intubationist on a 5 point scale: 1- Very Easy 2- Easy 3- Slight Resistance 4- Difficult 5- Not Possible. Separate scores will be recorded for LMA Insertion, Tube Insertion, and aScope Insertion (Group 1 patients).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-Operative Discomfort</measure>
    <time_frame>Duration of stay in Post-Anesthesia Care Unit (Approximately 1-2 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The patient will be assessed for Post-Operative Hoarseness, Sore Mouth, Sore Neck, Sore Jaw, Dysphonia, Dysphagia and Altered Tongue Sensation on entrance to Post-Anesthesia Care United (PACU) and on exit from PACU.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>LMA Cuff Sealing Properties</measure>
    <time_frame>Following LMA Insertion (Approximately 3-5 minutes)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Following LMA Insertion, the LMA cuff pressure will be calibrated using a manometer until it is 60-70 cm H2O. Leak pressure will then be assessed.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Laryngeal Mask Airways as a Conduit for Intubation</condition>
  <arm_group>
    <arm_group_label>AMBU Aura-I/aScope 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First, the AMBU Aura-I LMA will be inserted. Then, then patient will be intubated with assistance of the AMBU aScope 2 disposable fiberoptic system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA Fastrach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The LMA Fastrach Single Use Laryngeal Mask Airway (The Laryngeal Mask Airway Company, California) will be placed, followed by blind intubation using the LMA Fastrach EndoTracheal Tube.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMBU Aura-I LMA and aScope 2 Disposable Fiberoptic Camera</intervention_name>
    <arm_group_label>AMBU Aura-I/aScope 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA Fastrach Single Use</intervention_name>
    <arm_group_label>LMA Fastrach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult surgical Candidates Aged 18-80 years

          -  ASA I-III

          -  Mallampati Score of I or II

          -  BMI ≤ 35 kg/m2

          -  Presenting for elective surgery

          -  Require General Endotracheal Anesthesia.

        Exclusion Criteria:

          -  Previously known difficult airway,

          -  Emergency status

          -  Require prone positioning

          -  Interincisor distance &lt; 2.5cm

          -  Thyromental distance &lt; 5cm

          -  Clinically suspected difficult airway

          -  Contraindications to LMA Insertion, such as Reflux disease

          -  Patients who do not require endotracheal intubation

          -  Indications for Rapid Sequence Induction (RSI)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carin A Hagberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Medical School at Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carin A Hagberg, MD</last_name>
    <phone>(713) 500-6200</phone>
    <email>Carin.A.Hagberg@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alfonso V Altamirano, MD</last_name>
    <phone>(713) 500-6304</phone>
    <email>Alfonso.V.Altamirano@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Hermann Hospital - Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carin A Hagberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Artime, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine Normand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lara Ferrario, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <lastchanged_date>August 2, 2012</lastchanged_date>
  <firstreceived_date>July 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Carin A. Hagberg</investigator_full_name>
    <investigator_title>Professor and Chair, Department of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Laryngeal Mask Airway</keyword>
  <keyword>LMA</keyword>
  <keyword>Intubation</keyword>
  <keyword>AMBU</keyword>
  <keyword>AScope</keyword>
  <keyword>Aura-I</keyword>
  <keyword>Fastrach</keyword>
  <keyword>Fiberoptic</keyword>
  <keyword>Disposable Fiberoptic</keyword>
  <keyword>Blind Intubation</keyword>
  <keyword>Fiberoptic Intubation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
